TY - JOUR
T1 - Periorbital infections caused by Group A streptococci
T2 - a case series
AU - Tinggaard, Michaela
AU - Johannesen, Thor Bech
AU - Hoffmann, Steen
AU - Andersen, Aase Bengaard
AU - Toft, Peter Bjerre
N1 - © 2025. The Author(s).
PY - 2026/1/16
Y1 - 2026/1/16
N2 - BACKGROUND: A surge in Group A streptococcus (GAS) infections has been described in the post-COVID-19 pandemic period. We reviewed cases with periorbital GAS infections at our institution during a 14-month period, including cases with necrotizing soft tissue infection (NSTI).METHODS: A single center retrospective case series was performed at the University Hospital of Copenhagen, Rigshospitalet, during January 2023 to February 2024 including all adult patients referred from secondary centers with a suspicion of periorbital NSTI. All cases were treated for periorbital skin and soft tissue infections with culture-confirmed group A streptococci in an eye swab, a tissue sample or blood cultures.RESULTS: Eleven cases with a median age of 72 (range 55-84) years with periorbital GAS infection were included. Four patients had diabetes, and one patient had eyelid surgery prior to the infection. Pre-admission symptoms included pain, swelling in the periorbital area, fever and/or a sore throat. Patients presented with fever, nausea, and/or confusion and clinical exams were noticeable for erythema and edema of the periorbital area with the eyelids fully closed on the affected side. Two cases had septic shock. Based on CT scans, six cases were diagnosed with pre-septal cellulitis and five cases were suspected of post-septal NSTI, which was confirmed by surgical debridement. The GAS isolates from tissue samples or blood cultures in these five cases were of type MLST 28 / emm 1.0 (M1 clone). Treatment included meropenem and clindamycin (n = 11), intravenous immunoglobulin (n = 4), surgical debridement (n = 5) and hyperbaric oxygen therapy (n = 3). One patient died in the intensive care unit. Two patients have permanently reduced visual acuity.CONCLUSION: We report an accumulation of cases with pre- or post-septal orbital GAS infections in which the majority had no evidence of immunosuppression or a triggering event such as trauma or surgery. All cases of invasive GAS infections were caused by the M1 clone.
AB - BACKGROUND: A surge in Group A streptococcus (GAS) infections has been described in the post-COVID-19 pandemic period. We reviewed cases with periorbital GAS infections at our institution during a 14-month period, including cases with necrotizing soft tissue infection (NSTI).METHODS: A single center retrospective case series was performed at the University Hospital of Copenhagen, Rigshospitalet, during January 2023 to February 2024 including all adult patients referred from secondary centers with a suspicion of periorbital NSTI. All cases were treated for periorbital skin and soft tissue infections with culture-confirmed group A streptococci in an eye swab, a tissue sample or blood cultures.RESULTS: Eleven cases with a median age of 72 (range 55-84) years with periorbital GAS infection were included. Four patients had diabetes, and one patient had eyelid surgery prior to the infection. Pre-admission symptoms included pain, swelling in the periorbital area, fever and/or a sore throat. Patients presented with fever, nausea, and/or confusion and clinical exams were noticeable for erythema and edema of the periorbital area with the eyelids fully closed on the affected side. Two cases had septic shock. Based on CT scans, six cases were diagnosed with pre-septal cellulitis and five cases were suspected of post-septal NSTI, which was confirmed by surgical debridement. The GAS isolates from tissue samples or blood cultures in these five cases were of type MLST 28 / emm 1.0 (M1 clone). Treatment included meropenem and clindamycin (n = 11), intravenous immunoglobulin (n = 4), surgical debridement (n = 5) and hyperbaric oxygen therapy (n = 3). One patient died in the intensive care unit. Two patients have permanently reduced visual acuity.CONCLUSION: We report an accumulation of cases with pre- or post-septal orbital GAS infections in which the majority had no evidence of immunosuppression or a triggering event such as trauma or surgery. All cases of invasive GAS infections were caused by the M1 clone.
KW - Aged
KW - Aged, 80 and over
KW - Anti-Bacterial Agents/therapeutic use
KW - COVID-19/epidemiology
KW - Fasciitis, Necrotizing/microbiology
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Retrospective Studies
KW - SARS-CoV-2
KW - Soft Tissue Infections/microbiology
KW - Streptococcal Infections/microbiology
KW - Streptococcus pyogenes/isolation & purification
KW - Post-septal
KW - Cellulitis
KW - Periorbital
KW - Pre-septal
KW - Group A streptococcus
KW - NSTI
UR - https://www.scopus.com/pages/publications/105029745967
U2 - 10.1186/s12879-025-12411-2
DO - 10.1186/s12879-025-12411-2
M3 - Journal article
C2 - 41545920
SN - 1471-2334
VL - 26
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
IS - 1
M1 - 317
ER -